UB Paderborn / Katalog / Suche / in CDI

1 – 18 von 18

Sortiert nach

Improving Risk Assessment in Clinical Trials: Toward a Systematic Risk-Based Monitoring Approach

Current therapeutic research, 2021-01, Vol.95, p.100643-100643, Article 100643

2021

Volltextzugriff (PDF)

Application of Statistical Methods for Central Statistical Monitoring and Implementations on the German Multiple Sclerosis Registry

Therapeutic innovation & regulatory science, 2023-11, Vol.57 (6), p.1217-1228

2023

Volltextzugriff (PDF)

Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations

Therapeutic advances in neurological disorders, 2024-01, Vol.17, p.17562864241233044-17562864241233044

2024

Volltextzugriff (PDF)

Piper crocatum Ruiz & Pav. ameliorates wound healing through p53, E-cadherin and SOD1 pathways on wounded hyperglycemia fibroblasts

Saudi journal of biological sciences, 2021-12, Vol.28 (12), p.7257-7268

2021

Volltextzugriff (PDF)

Management of MS Patients Treated With Daclizumab – a Case Series of 267 Patients

Frontiers in neurology, 2020-09, Vol.11

2020

Volltextzugriff (PDF)

Patient Benefit of Clinical Research in Diversely Advanced African Developing Countries

Current therapeutic research, 2022-01, Vol.96, p.100656-100656, Article 100656

2022

Volltextzugriff (PDF)

Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry

Therapeutic advances in neurological disorders, 2024-01, Vol.17, p.17562864241239740-17562864241239740

2024

Volltextzugriff (PDF)

SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study

The Lancet regional health. Europe, 2022-11, Vol.22, p.100502-100502, Article 100502

2022

Volltextzugriff (PDF)

Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study

Journal of clinical medicine, 2023-05, Vol.12 (11), p.3640

2023

Volltextzugriff (PDF)

Occurrence and Risk Factors of Relapse Activity after Vaccination against COVID-19 in People with Multiple Sclerosis: 1-Year Follow-Up Results from a Nationwide Longitudinal Observational Study

Vaccines (Basel), 2023-12, Vol.11 (12), p.1859

2023

Volltextzugriff (PDF)

Birch pollen-induced signatures in dendritic cells are maintained upon additional cytomegalovirus exposure

Gene, 2024-11, Vol.927, p.148649, Article 148649

2024

Volltextzugriff (PDF)

Rolle von Komorbiditäten bei Multipler Sklerose nicht unterschätzen

NeuroTransmitter, 2022-04, Vol.33 (4), p.40-44

2022

Volltextzugriff (PDF)

Aggressive multiple sclerosis: a matter of measurement and timing

Brain (London, England : 1878), 2020-12, Vol.143 (11), p.e97-e97

2020

Volltextzugriff (PDF)

Status Quo Of Healthcare Systems and Their Impact on Pharmaceutical Industry Performance in African Developing Countries: A Scoping Review

Global bioethics enquiry, 2023-12, Vol.10 (3), p.119-133

2023

Volltextzugriff (PDF)

The Temporal Development of Clinical Research in Emerging Countries

American journal of clinical and experimental medicine (Print), 2021, Vol.9 (1), p.1

2021

Volltextzugriff (PDF)

Characteristics of secondary progressive multiple sclerosis: Disease activity and provision of care in Germany – A registry-based/multicentric cohort study

Multiple sclerosis and related disorders, 2021-11, Vol.56, p.103281-103281, Article 103281

2021

Volltextzugriff (PDF)

Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry

Neurology and therapy, 2022-03, Vol.11 (1), p.319-336

2022

Volltextzugriff (PDF)

Management of MS Patients Treated With Daclizumab - a Case Series of 267 Patients

Frontiers in neurology, 2020, Vol.11, p.996-996

2020

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(17)
Berichte
(1)

Sprache

Englisch
(17)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Improving Risk Assessment in Clinical Trials: Toward a Systematic Risk-Based Monitoring Approach

Application of Statistical Methods for Central Statistical Monitoring and Implementations on the German Multiple Sclerosis Registry

Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations

Piper crocatum Ruiz & Pav. ameliorates wound healing through p53, E-cadherin and SOD1 pathways on wounded hyperglycemia fibroblasts

Management of MS Patients Treated With Daclizumab – a Case Series of 267 Patients

Patient Benefit of Clinical Research in Diversely Advanced African Developing Countries

Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry

SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study

Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study

Occurrence and Risk Factors of Relapse Activity after Vaccination against COVID-19 in People with Multiple Sclerosis: 1-Year Follow-Up Results from a Nationwide Longitudinal Observational Study

Birch pollen-induced signatures in dendritic cells are maintained upon additional cytomegalovirus exposure

Rolle von Komorbiditäten bei Multipler Sklerose nicht unterschätzen

Aggressive multiple sclerosis: a matter of measurement and timing

Status Quo Of Healthcare Systems and Their Impact on Pharmaceutical Industry Performance in African Developing Countries: A Scoping Review

The Temporal Development of Clinical Research in Emerging Countries

Characteristics of secondary progressive multiple sclerosis: Disease activity and provision of care in Germany – A registry-based/multicentric cohort study

Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry

Management of MS Patients Treated With Daclizumab - a Case Series of 267 Patients

Suchergebnisse filtern